UK MHRA Approval Received for First-In-Human Trial of Rincell-1, a First-In-Class Regenerative Cell Therapy for Sensorineural Hearing Loss
UK MHRA Approval Received for First-In-Human Trial of Rincell-1, a First-In-Class Regenerative Cell Therapy for Sensorineural Hearing Loss Rincell-1 addresses a multi $Bn global market opportunity where no disease modifying treatments currently exist GlobeNewswire July 01, 2025 Sheffield, July 01, 2025 (GLOBE NEWSWIRE) — UK MHRA Approval Received for First-In-Human Trial of Rincell-1, a First-In-Class […]